Skip to main content
. Author manuscript; available in PMC: 2015 Apr 29.
Published in final edited form as: Depress Anxiety. 2012 Jun 11;29(10):883–890. doi: 10.1002/da.21967

TABLE 1.

Demographic and clinical characteristics of remitters after phase I and II

Gender (M/F) 25/36
Age (mean ± SD) 49.1 ± 11.6
Number of failed medication trials (mean ± SD) 2 ± 1.7
Level of resistance (ATHF: mean ± SD) 2.9 ± 0.7
Number of weeks of TMS treatment (mean ± SD) 7.3 ± 2.8
Baseline HDRS-24 (mean ± SD) 25.7 ± 4.8
HDRS-24 at the end of phase I and II (mean ± SD) 5.8 ± 2.3

M, Male; F, Female; ATHF, Antidepressant Treatment History Form; HDRS-24, Hamilton Rating Scale for depression.